Circularity Capital is a specialist private equity firm founded to deliver value for investors from the opportunities created by the circular economy.
We use the circular economy as a framework to support investee businesses in decoupling their growth from resource constraints, enhance resource productivity and drive competitive advantage.
Our team has specific expertise and a powerful network in the circular economy which we use to identify, source and secure proprietary investment opportunities and add value to portfolio businesses through access to talent, market information and new business development opportunities.
Our investors include financial institutions, global corporations and leading family offices.
At the heart of Circularity Capital’s ability to create value for investors is a focus on combining specialist expertise in the circular economy with institutional quality private equity experience.
Circularity Capital LLP is authorised and regulated by the Financial Conduct Authority.
We use the circular economy as a framework to support investee businesses in decoupling their growth from resource constraints, enhance resource productivity and drive competitive advantage.
Our team has specific expertise and a powerful network in the circular economy which we use to identify, source and secure proprietary investment opportunities and add value to portfolio businesses through access to talent, market information and new business development opportunities.
Our investors include financial institutions, global corporations and leading family offices.
At the heart of Circularity Capital’s ability to create value for investors is a focus on combining specialist expertise in the circular economy with institutional quality private equity experience.
Circularity Capital LLP is authorised and regulated by the Financial Conduct Authority.
Location: United Kingdom, Scotland, City of Edinburgh
Employees: 1-10
Founded date: 2015
Investment Type: Private Equity Firm
Investment Stage: Private Equity
Portfolio 10
| Date | Name | Website | Total Raised | Location |
| 07.12.2022 | CERAFILTEC | cerafiltec.com | $31.38M | Germany, S... |
| 17.02.2022 | Cocogreen | cocogreen.co.uk | - | United Kin... |
| 07.02.2022 | Lendis | lendis.io | - | - |
| 27.12.2021 | P2i | p2i.com | - | United Kin... |
| 30.07.2018 | Grover | getgrover.com | $2.35B | Germany, B... |
| - | Shark Solu... | shark-solutions.com | - | - |
| - | PackBenefi... | packbenefit.eco | - | Canada, On... |
| - | Green Home... | greenhomesystems.co.uk | - | United Kin... |
| - | ZigZag Glo... | zigzag.global | $19M | United Kin... |
| - | Winnow | winnowsolutions.com | $30.72M | United Kin... |
Mentions in press and media 15
| Date | Title | Description |
| 24.01.2026 | Digital Health Leader Oviva Secures $200M for Chronic Care Expansion | Oviva, a European digital health pioneer, closed a $200 million Series D funding round. Kinnevik led the investment, becoming its largest shareholder. The company offers AI-powered virtual care for chronic conditions like obesity. Its evide... |
| 22.01.2026 | HealthTech Oviva erhält 200 Millionen – Decathlon übernimmt Rebike – Kolsquare kauft Storyclash | Im #DealMonitor für den 22. Januar werfen wir einen Blick auf die wichtigsten, spannendsten und interessantesten Investments und Exits des Tages in der DACH-Region. Alle Deals der Vortage gibt es im großen und übersichtlichen #DealMonitor-A... |
| 02.07.2025 | The Dance of Corporate Strategy: Fiskars and Matsmart in Focus | In the world of business, every move counts. Companies are like chess players, strategizing their next steps. Two recent corporate actions illustrate this perfectly: Fiskars Corporation's share buyback and Matsmart Group's impressive revenu... |
| 01.07.2025 | Matsmart Group Results 2024: Strong Revenue Growth with Improved Profitability | Matsmart Group Results 2024: Strong Revenue Growth with Improved Profitability Tue, Jul 01, 2025 08:30 CET Report this content On May 21, 2025, the Annual General Meeting adopted the Annual and Sustainability Report for 2024. Growth amounte... |
| 23.10.2024 | Rebike sammelt 13 Millionen ein – Dunia erhält 11,5 Millionen – Rivean übernimmt Perbility | Im #DealMonitor für den 22. Oktober werfen wir einen Blick auf die wichtigsten, spannendsten und interessantesten Investments und Exits des Tages in der DACH-Region. Alle Deals der Vortage gibt es im großen und übersichtlichen #DealMonitor-... |
| 03.06.2024 | Matsmart-Motatos' consolidated results in 2023: Turnover of over 1 billion SEK with improved cash flow | Matsmart-Motatos' consolidated results in 2023: Turnover of over 1 billion SEK with improved cash flow Mon, Jun 03, 2024 08:00 CET Report this content On 30 May 2024, the annual and sustainability report for 2023 was adopted by the Annual G... |
| 23.11.2023 | The Week in AgriFoodTech: Matsmart-Motatos grabs $43m to save food waste, RED Horticulture bags $18m, TômTex makes leather from fish | This week, Matsmart-Motatos scored new funding for its e-commerce business that sells overstock dry goods to stop food waste. RED Horticulture raised capital for its LED greenhouse lighting tech, and alternative leather startup TômTex bagge... |
| 20.11.2023 | Matsmart-Motatos closes oversubscribed capital round led by circular specialist investor Circularity Capital | Matsmart-Motatos closes oversubscribed capital round led by circular specialist investor Circularity Capital Mon, Nov 20, 2023 07:00 CET Report this content Matsmart-Motatos, the leading European D2C e-commerce retailer of overstock dry foo... |
| 24.11.2022 | Dedicated growth equity private equity fund manager Circularity Capital invests £10m in ACS Clothing | LR - Andrew Rough (ACS) Andrew Shannon (Circularity Capital) ACS clothing EDINBURGH, SCOTLAND, UNITED KINGDOM, November 24, 2022 /EINPresswire.com/ -- Advanced Clothing Solutions (ACS), the UK's leading circular and sustainable fashion enab... |
| 08.07.2021 | Brandon Capital leads $14m investment to develop new cancer drug | A new spinout from the University of Otago has secured $14 million in backing to help develop a new kind of targeted cancer drug in the emerging field of RNA therapy. |
Show more